{
    "organizations": [],
    "uuid": "8006158fe7d35cea7c39c9483a9b77c5f8cd8d45",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/axovant-sciences-moves-ceo/drug-developer-axovants-ceo-coo-step-down-idUSL4N1Q2417",
    "ord_in_thread": 0,
    "title": "Drug developer Axovant's CEO, COO step down",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 12 (Reuters) - Axovant Sciences Ltd on Monday said Chief Executive Officer David Hung had resigned, nearly a year after his appointment.\nChief Operating Officer Marion McCourt has also stepped down, along with three members of the drug developerâ€™s board.\nThe company named Pavan Cheruvu as its new CEO. (Reporting by Manas Mishra in Bengaluru; Editing by Maju Samuel)\n ",
    "published": "2018-02-12T20:16:00.000+02:00",
    "crawled": "2018-02-13T15:54:32.004+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "axovant",
        "science",
        "ltd",
        "monday",
        "said",
        "chief",
        "executive",
        "officer",
        "david",
        "hung",
        "resigned",
        "nearly",
        "year",
        "appointment",
        "chief",
        "operating",
        "officer",
        "marion",
        "mccourt",
        "also",
        "stepped",
        "along",
        "three",
        "member",
        "drug",
        "developer",
        "board",
        "company",
        "named",
        "pavan",
        "cheruvu",
        "new",
        "ceo",
        "reporting",
        "manas",
        "mishra",
        "bengaluru",
        "editing",
        "maju",
        "samuel"
    ]
}